| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-6851(00)00304-2 |
| P698 | PubMed publication ID | 11087922 |
| P2093 | author name string | Theisen M | |
| Jepsen S | |||
| Vuust J | |||
| de Stricker K | |||
| Oeuvray C | |||
| P2860 | cites work | Mating patterns in malaria parasite populations of Papua New Guinea. | Q44168508 |
| The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal | Q44171038 | ||
| Plasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction | Q44203030 | ||
| Plasmodium falciparum: Restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil | Q44583876 | ||
| Naturally acquired antibodies to the glutamate-rich protein are associated with protection against plasmodium falciparum malaria | Q46163143 | ||
| Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. | Q47859285 | ||
| New B cell epitopes in thePlasmodium falciparum malaria circumsporozoite protein | Q47863134 | ||
| Mutations with multiple independent origins in surface antigens mark the targets of biological selective pressure | Q47873345 | ||
| Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. | Q48078178 | ||
| Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein | Q58423834 | ||
| Malaria vaccines | Q67548370 | ||
| Primary structure and localization of a conserved immunogenicPlasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle | Q27974520 | ||
| Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing | Q30897109 | ||
| Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development | Q36958381 | ||
| Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso. | Q37066114 | ||
| In vivo and in vitro derived Palo Alto lines of Plasmodium falciparum are genetically unrelated | Q38890586 | ||
| Efficacy trial of malaria vaccine SPf66 in Gambian infants | Q38959070 | ||
| Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal | Q39515540 | ||
| The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro | Q39569469 | ||
| Genetic analysis of host-parasite coevolution in human malaria | Q40840674 | ||
| Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages | Q41835030 | ||
| Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal | Q43664462 | ||
| Random mating in a natural population of the malaria parasite Plasmodium falciparum | Q43954691 | ||
| P433 | issue | 1 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 123-130 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Molecular and Biochemical Parasitology | Q15752756 |
| P1476 | title | Conservation and heterogeneity of the glutamate-rich protein (GLURP) among field isolates and laboratory lines of Plasmodium falciparum | |
| P478 | volume | 111 |
| Q39520295 | A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages |
| Q33987686 | A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children |
| Q30332285 | A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas--XVI. Asembo Bay Cohort Project. |
| Q47973517 | A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate |
| Q44575916 | Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth |
| Q37361179 | Assessing malaria transmission in a low endemicity area of north-western Peru. |
| Q36227049 | Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich pro |
| Q43245288 | Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. |
| Q24804829 | Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray |
| Q41632119 | Genetic Diversity and Allelic Frequency of Glutamate-Rich Protein (GLURP) in Plasmodium falciparum Isolates from Sub-Saharan Africa |
| Q48023074 | Genetic Diversity of the Plasmodium falciparum Glutamate-Rich Protein R2 Region Before and Twelve Years after Introduction of Artemisinin Combination Therapies among Febrile Children in Nigeria |
| Q36142562 | Genetic diversity of Plasmodium falciparum isolates from Baka Pygmies and their Bantu neighbours in the north of Gabon |
| Q46286513 | Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India |
| Q37675077 | Genetic polymorphisms in the glutamate-rich protein of Plasmodium falciparum field isolates from a malaria-endemic area of Brazil |
| Q34389610 | Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine |
| Q48034345 | Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial |
| Q30897109 | Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing |
| Q38882265 | Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels |
| Q33305467 | Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. |
| Q35907030 | Medicinal application of long synthetic peptide technology |
| Q37418354 | Population genomics diversity of Plasmodium falciparum in malaria patients attending Okelele Health Centre, Okelele, Ilorin, Kwara State, Nigeria |
| Q36394182 | Recent advances in recombinant protein-based malaria vaccines |
| Q34008755 | Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity |
| Q33239047 | Sequence variation in the T-cell epitopes of the Plasmodium falciparum circumsporozoite protein among field isolates is temporally stable: a 5-year longitudinal study in southern Vietnam |
| Q40749062 | Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen |
| Q38658724 | The GMZ2 malaria vaccine: from concept to efficacy in humans. |
| Q34168118 | The evolutionary genomics of pathogen recombination |
| Q37471465 | The future for blood-stage vaccines against malaria |
Search more.